Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Lack of Diversity in Genetic Datasets is Risky for Treating Disease
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.
In chapter 5, “Resurgence: Bedbugs Bite Back,” author Emily Monosson chronicles the rise of the pesky pests in the face of humanity’s best chemical efforts.